Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + UDCA in Primary Biliary Cholangitis
NCT02823353Phase 3Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Apr 2016
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by Xijing Hospital of Digestive Diseases. Started Apr 2016; status: completed.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02823353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823353.